Volume 27, Number 12—December 2021
Research
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Households with Children, Southwest Germany, May–August 2020
Table 3
Index case symptom or hospitalization | No. index cases, n = 393 | No. exposed, n = 1182 | No. seropositive exposed, n = 390 |
Observed SAR, % | Predicted SAR, % (IQR)† | Odds ratio (95% CI)† | p value† |
---|---|---|---|---|---|---|---|
Fever | 225 | 666 | 253 | 38.0 | 36.8 (11.8–58.4) | 1.93 (1.14–3.31) | 0.015 |
Cough | 236 | 717 | 272 | 37.9 | 36.8 (11.7–58.2) | 2.07 (1.21–3.53) | 0.008 |
Diarrhea | 91 | 271 | 94 | 34.7 | 33.2 (9.34–54.5) | 0.80 (0.43–1.49) | 0.481 |
Dysgeusia |
253 |
748 |
252 |
33.7 |
32.2 (10.4–48.7) |
1.41 (0.82–2.43) |
0.213 |
Hospitalization | 22 | 67 | 30 | 44.8 | 43.9 (15.2–68.9) | 1.22 (0.40–3.75) | 0.726 |
*IQR, interquartile range; NA, not applicable; SAR, secondary attack rate. †The predicted SARs, odds ratios, and p values were calculated from a multivariable generalized linear mixed-effects logistic regression model. The respective references were absence of the symptom or “hospitalization” and adjusted for age of index case-patient as a numeric variable (OR 1.04, 95% CI 1.01–1.06; p = 0.0055).
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.
Page created: September 16, 2021
Page updated: November 19, 2021
Page reviewed: November 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.